CVRx (CVRX) vs Elutia (ELUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Elutia (ELUT) has outperformed CVRx (CVRX) over the past year, losing 6.9% versus a loss of 81.6%. Over five years, ELUT leads with a -84.8% price change compared with -89.3% for CVRX. CVRx is the larger company by market cap ($44.8 million vs $36.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | ELUT |
|---|---|---|
| Share price | $1.68 | $0.8273 |
| Market cap | $44.76M | $36.64M |
| 1-day change | +0.60% | +0.88% |
| YTD return | -76.34% | +19.38% |
| 1-year return | -81.56% | -6.94% |
| 5-year return | -89.27% | -84.82% |
| EPS (TTM) | $-1.97 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $1.39 |
| 52-week low | $1.50 | $0.50 |
| Distance from 52-week high | -85.13% | -40.27% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +172.62% | +504.38% |
| Average volume | 922.12K | 185.82K |
| Shares outstanding | 26.64M | 44.29M |
| Employees | 223 | 25 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed CVRX by 74.6 percentage points over the past year.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Healthcare · Medical Devices · 223 employees
About Elutia
ELUT stock →Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.
Healthcare · Medical Devices · 25 employees
CVRX vs ELUT FAQ
Which is bigger, CVRx or Elutia?
CVRx (CVRX) is larger, with a market capitalization of $44.76M compared with $36.64M for Elutia (ELUT).
Which stock has performed better over the past year, CVRX or ELUT?
ELUT returned -6.94% over the past 12 months, compared with -81.56% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and Elutia in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.